Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

CanCell Therapeutics

France 8 Rue Docteur Jean Francois Xavier Girod, 25000 Besançon, France

About the sponsor

CanCell Therapeutics focuses its clinical research on relapsed/refractory acute myeloid leukemia, with activity centered on patients whose disease has returned or has not responded adequately to prior treatment.

  • Acute myeloid leukemia
  • Relapsed disease
  • Refractory disease

The company’s research interest is directed toward treatment settings in which hematologic cancer control remains a major clinical need.

About Specializations

CanCell Therapeutics runs clinical trials in conditions such as Acute myeloid leukaemia refractory, Acute myeloid leukaemia recurrent, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Acute myeloid leukaemia refractory+1

Not yet recruiting

Study on CCTx-001, Cyclophosphamide Monohydrate, and Fludarabine Phosphate for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:CCTX-001
  • Sponsor:CanCell Therapeutics

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.